Clinicopathologic behavior of gastric adenocarcinoma in Hispanic patients: Analysis of a single institution's experience over 15 years

Journal of Clinical Oncology

Volumn 23, Issue 13, 2005, Pages 3094-3103

  Yao, James C ^a   Tseng, Jennifer F ^a   Worah, Samidha ^a   Hess, Kenneth R ^a   Mansfield, Paul F ^a   Crane, Christopher H ^a   Schnirer, Isac I ^a   Ready, Satish ^a   Chiang, Silvia S ^a   Najam, Azmeena ^a   Yu, Christina ^a   Giacco, Geoffrey G ^a   Xie, Keping ^a   Wu, Tsung Teh ^a   Feig, Barry W ^a   Pisters, Peter W T ^a   Ajani, Jaffer A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; ASIAN; CANCER ADJUVANT THERAPY; CANCER CENTER; CANCER STAGING; DISEASE COURSE; ETHNICITY; FEMALE; HISPANIC; HISTOPATHOLOGY; HUMAN; KAPLAN MEIER METHOD; LIVER METASTASIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUCINOUS CARCINOMA; MULTIVARIATE ANALYSIS; ONSET AGE; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REVIEW; STOMACH ADENOCARCINOMA; SURVIVAL; TOTAL STOMACH RESECTION; TUMOR LOCALIZATION; ADENOCARCINOMA; AGED; ARTICLE; CAUCASIAN; COMPARATIVE STUDY; METASTASIS; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; STOMACH TUMOR;

ADENOCARCINOMA; ADULT; AFRICAN AMERICANS; AGE OF ONSET; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 21144437396     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.08.987     Document Type: Review

References (64)

1. Society AC: Cancer Facts and Figures for Hispanics/Latinos 2003-2005. Altanta, GA, American Cancer Society, 2003. http://www .census.gov/ipc/www/ usinterimproj/
2. U.S. Interim Projections by Age, Sex, Race, and Hispanic Origin, 2004
3. El-Serag HB, Sonnenberg A: Ethnic variations in the occurrence of gastroesophageal cancers. J Clin Gastroenterol 28:135-139, 1999
4. Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA Cancer J Clin 54:8-29, 2004
5. Sasako M: Principles of surgical treatment for curable gastric cancer. J Clin Oncol 21:274s-275s, 2003 (suppl)
6. Maruyama K, Sasako M, Kinoshita T, et al: Surgical treatment for gastric cancer: The Japanese approach. Semin Oncol 23:360-368, 1996
7. Lee WJ, Lee WC, Houng SJ, et al: Survival after resection of gastric cancer and prognostic relevance of systematic lymph node dissection: Twenty years experience in Taiwan. World J Surg 19:707-713, 1995
8. Mok YJ, Koo BW, Whang CW, et al: Cancer of the stomach: A review of two hospitals in Korea and Japan. World J Surg 17:777-782, 1993
9. Theuer CP: Asian gastric cancer patients at a southern California comprehensive cancer center are diagnosed with less advanced disease and have superior stage-stratified survival. Am Surg 66:821-826, 2000
10. Gill S, Shah A, Le N, et al: Asian ethnicity-related differences in gastric cancer presentation and outcome among patients treated at a Canadian cancer center. J Clin Oncol 21:2070-2076, 2003
11. Hall TJ, Moulder J, Hsu HS, et al: Gastric carcinoma among younger individuals in Mississippi. South Med J 86:302-304, 1993
12. Vaquerano J, Esemuede N, Odocha O, et al: Gastric carcinoma in African Americans: A 10 year single center analysis. In Vivo 10:233-235, 1996
13. Theuer CP, Kurosaki T, Ziogas A, et al: Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer 89:1883-1892, 2000
14. Wu AH, Crabtree JE, Bernstein L, et al: Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 103:815-821, 2003
15. Pezzi JS, Shiau YF: Helicobacter pylori and gastrointestinal disease. Am Fam Physician 52: 1717-1724, 1729, 1995
16. Schlemper R, Itabashi M, Kato Y, et al: Differences in diagnostic criteria for gastric carcinoma between Japanese and Western pathologists. Lancet 349:1725-1729, 1997
17. Fennerty MB, Emerson JC, Sampliner RE, et al: Gastric intestinal metaplasia in ethnic groups in the southwestern United States. Cancer Epidemiol Biomarkers Prev 1:293-296, 1992
18. Vo QN, Geradts J, Gulley ML, et al: Epstein-Barr virus in gastric adenocarcinomas: Association with ethnicity and CDKN2A promoter methylation. J Clin Pathol 55:669-675, 2002
19. Miller BA, Kolonel LN: National Cancer Institute (U.S.). Cancer Control Research Program: Racial/ethnic patterns of cancer in the United States, 1988-1992. Washington DC, United States Department of Health and Human Services National Institute of Health, 1996
20. Blot WJ, Devesa SS, Kneller RW, et al: Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 265:1287-1289, 1991
21. Pera M, Cameron AJ, Trastek VF, et al: Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 104:510-513, 1993
22. Zheng T, Mayne S, Holford T, et al: The time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut from 1955-1989. Cancer 72:330-340, 1993
23. Chow WH, Blot WJ, Vaughan TL, et al: Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90:150-155, 1998
24. Yao JC, Schnirer II, Reddy S, et al: Effects of sex and racial/ethnic group on the pattern of gastric cancer localization. Gastric Cancer 5:208-212, 2002
25. Morson B: Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa. Br J Cancer 9:377-385, 1955
26. Blackburn EK, Callender ST, Dacie JV, et al: Possible association between pernicious anaemia and leukaemia: A prospective study of 1,625 patients with a note on the very high incidence of stomach cancer. Int J Cancer 3:163-170, 1968
27. Brinton LA, Gridley G, Hrubec Z, et al: Cancer risk following pernicious anaemia. Br J Cancer 59:810-813, 1989
28. Hsing AW, Hansson LE, McLaughlin JK, et al: Pernicious anemia and subsequent cancer: A population-based cohort study. Cancer 71:745-750, 1993
29. Asaka M: Helicobacter pylori infection and gastric cancer. Intern Med 41:1-6, 2002
30. Forman D, Newell DG, Fullerton F, et al: Association between infection with Helicobacter pylori and risk of gastric cancer: Evidence from a prospective investigation. BMJ 302:1302-1305, 1991
31. Parsonnet J, Friedman GD, Orentreich N, et al: Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40:297-301, 1997
32. Nomura A, Stemmermann GN, Chyou PH, et al: Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 325:1132-1136, 1991
33. Chow WH, Blaser MJ, Blot WJ, et al: An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 58:588-590, 1998
34. Staszewski J: Migrant studies in alimentary tract cancer. Recent Results Cancer Res 39:85-97, 1972
35. Correa P, Cuello C, Duque E, et al: Gastric cancer in Colombia: III. Natural history of precursor lesions. J Natl Cancer Inst 57:1027-1035, 1976
36. Coggon D, Osmond C, Barker DJ: Stomach cancer and migration within England and Wales. Br J Cancer 61:573-574, 1990
37. Galanis DJ, Kolonel LN, Lee J, et al: Intakes of selected foods and beverages and the incidence of gastric cancer among the Japanese residents of Hawaii: A prospective study. Int J Epidemiol 27:173-180, 1998
38. Wanebo HJ, Kennedy BJ, Chmiel J, et al: Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg 218:583-592, 1993
39. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 88:921-932, 2000
40. Baffa R, Veronese ML, Santoro R, et al: Loss of FHIT expression in gastric carcinoma. Cancer Res 58:4708-4714, 1998
41. Vaughan TL, Davis S, Kristal A, et al: Obesity, alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 4:85-92, 1995
42. Lagergren J, Bergstrom R, Nyren O: Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med 130:883-890, 1999
43. Inoue M, Tajima K, Hirose K, et al: Lifestyle and subsite of gastric cancer: Joint effect of smoking and drinking habits. Int J Cancer 56: 494-499, 1994
44. Lagergren J, Bergstrom R, Lindgren A, et al: The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer 85:340-346, 2000
45. Gammon MD, Schoenberg JB, Ahsan H, et al: Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89:1277-1284, 1997
46. Horii A, Nakatsuru S, Miyoshi Y, et al: The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res 52:3231-3233, 1992
47. Wu MS, Shun CT, Wang HP, et al: Genetic alterations in gastric cancer: Relation to histological subtypes, tumor stage, and Helicobacter pylori infection. Gastroenterology 112:1457-1465, 1997
48. Hsieh LL, Huang YC: Loss of heterozygosity of APC/MCC gene in differentiated and undifferentiated gastric carcinomas in Taiwan. Cancer Lett 96:169-174, 1995
49. Rhyu MG, Park WS, Jung YJ, et al: Allelic deletions of MCC/APC and p53 are frequent late events in human gastric carcinogenesis. Gastroenterology 106:1584-1588, 1994
50. Graziano F, Cascinu S, Staccioli MP, et al: Potential role and chronology of abnormal expression of the Deleted in Colon Cancer (DCC) and the p53 proteins in the development of gastric cancer. BMC Cancer 1:9, 2001
51. Fang DC, Jass JR, Wang DX: Loss of heterozygosity and loss of expression of the DCC gene in gastric cancer. J Clin Pathol 51:593-596, 1998
52. Ottini L, Palli D, Falchetti M, et al: Microsatellite instability in gastric cancer is associated with tumor location and family history in a high-risk population from Tuscany. Cancer Res 57: 4523-4529, 1997
53. Fang DC, Jass JR, Wang DX, et al: Infrequent loss of heterozygosity of APC/MCC and DCC genes in gastric cancer showing DNA microsatellite instability. J Clin Pathol 52:504-508, 1999
54. Guo RJ, Arai H, Kitayama Y, et al: Microsatellite instability of papillary subtype of human gastric adenocarcinoma and hMLH1 promoter hypermethylation in the surrounding mucosa. Pathol Int 51:240-247, 2001
55. Hirohashi S: Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Arm J Pathol 153:333-339, 1998
56. Tamura G, Sakata K, Nishizuka S, et al: Inactivation of the E-cadherin gene in primary gastric carcinomas and gastric carcinoma cell lines. Jpn J Cancer Res 87:1153-1159, 1996
57. Becker K, Atkinson M, Reich U, et al: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 54: 3845-3852, 1994
58. Suzuki H, Itoh F, Toyota M, et al: Distinct methylation pattern and microsatellite instability in sporadic gastric cancer. Int J Cancer 83:309-313, 1999
59. Tamura G, Yin J, Wang S, et al: E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst 92: 569-573, 2000
60. American Anthropological Association: American Anthropological Association statement on race. Am Anthropol 100:712-713, 1998
61. Parra FC, Amado RC, Lambertucci JR, et al: Color and genomic ancestry in Brazilians. Proc Natl Acad Sci U S A 100:177-182, 2003
62. Cooper RS, Kaufman JS, Ward R: Race and genomics. N Engl J Med 348:1166-1170, 2003
63. Schmitt E: For 7 million people in census, one race category isn't enough. The New York Times, March 13, 2001, section A, p 1
64. Diverse Hispanic population to become largest U.S. minority. Popul Today 25:1-2, 1997